Reports for PURDUE PHARMA
Company Name
PURDUE PHARMA
Totals |
||
Shortage reports |
140 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 1 (1%) | |
Resolved: | 139 (99%) | |
Discontinuation Reports |
5 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 5 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG | 24MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-05-20 | 2022-07-22 | 161054 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG | 30MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-03-02 | 2022-04-28 | 155885 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-01-25 | 2021-02-18 | 132378 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-03-03 | 2021-03-16 | 135014 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-04-23 | 2021-06-05 | 138032 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-06-14 | 2021-07-06 | 140892 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-07-09 | 2021-07-14 | 142283 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-11-03 | 2021-11-30 | 148717 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-01-26 | 2022-02-23 | 153555 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-04-21 | 2022-06-10 | 159244 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 3MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-06-24 | 2022-07-22 | 163413 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG | 6MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-08-06 | 2021-09-01 | 143749 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG | 6MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2021-09-21 | 2021-10-30 | 145955 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG | 6MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-04-15 | 2022-04-28 | 158904 |
HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG | 6MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-06-23 | 2022-07-30 | 163383 |
MS CONTIN | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-10 | 2022-12-08 | 174235 |
MS CONTIN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-10 | 2022-12-08 | 174238 |
MS CONTIN | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-08-04 | 2021-10-02 | 143634 |
MS.IR | 10MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2021-07-26 | 2021-12-10 | 143048 |
MS.IR | 10MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2024-03-21 | 2024-03-28 | 222882 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
BELBUCA | 75MCG | FILM, SOLUBLE | Discontinued | 2019-03-28 | 2019-04-02 | 79766 |
BELBUCA | 150MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80230 |
BELBUCA | 300MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80233 |
BELBUCA | 450MCG | FILM, SOLUBLE | Discontinued | 2019-04-01 | 2019-04-02 | 80236 |
DILAUDID | 1MG | Discontinued | 2018-03-01 | 2018-03-02 | 41479 |
Showing 1 to 5 of 5